The benefits of publishing in the Journal of Herbmed Pharmacology:
- Free access to all articles
- Fast and constructive peer review process (one month)
- Easy and quick online submission
- Rapid publication
Terms of submission
Unsolicited manuscripts will be reviewed for publication with the following understanding:
1. The paper represents an original work.
2. The paper neither has been published already nor is being under review elsewhere.
3. Upon acceptance, the paper may not be published elsewhere without the permission of Journal of Herbmed Pharmacology.
4. The published paper is the sole property of Journal of Herbmed Pharmacology and may be edited before publication.
Manuscripts should be submitted by one of the authors of the manuscript through the online system or Editor-in-Chief's Email (email@example.com). The submitting author is responsible for ensuring that the article's publication has been approved by all the other coauthors. It is also the authors' responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution. The submitting author takes responsibility for the paper during submission and peer review.
Correspondence and proofs will be sent to the author(s) before publication unless otherwise indicated. It is a condition of submission of a paper that the authors permit editing of the paper for readability. All enquiries concerning the publication of accepted papers should be addressed to firstname.lastname@example.org. If for some technical reasons submission through site is not possible, the author can contact email@example.com for support.
All manuscripts are subject to peer review and are expected to meet standards of academic excellence. Submissions will be considered by technical editor and section editor and “if not rejected right away” by peer-reviewers,
Article Processing Charges
There is no processing charge for open access Journal of Herbmed Pharmacology.
Structure and Preparation of Manuscripts
Units of measurement should be presented simply and concisely using System International (SI) units.
Types of Articles
Manuscripts should be presented as one of the following formats.
Full Original Researches
A full length original research article (up to ~5000 words, including tables, figures and references) presents novel findings relevant to the aims and scope of the journal.
A full length critical review (up to ~8000 words, including tables, figures and references) provides an abstract and discussion of the relevant literature about any topic covered within the aims and scope of the journal. Review articles should be sharply focused, well-focused, well-documented examinations of timely related issues.
Mini Reviews are sharply focused, well-focused, well-documented examinations of timely related issues (up to ~4000 words, including tables, figures and references). The issues may be of a controversial nature, or may address a more narrowly focused area than those typically covered in a review.
Short Communications are preliminary reports (up to ~2000 words, including tables, figures and references).
Commentaries present the author’s considered opinion (up to ~1000 words limited to one figure/table and limited references) on an original article to be published in the journal and usually submitted by the reviewers.
These reports should include introduction, case description, discussion and conclusions. Patient confidentiality must be maintained. Any identifying information must not be published, and any specific details or description that may compromise patient anonymity, should be omitted. The patient’s consent should be obtained when possible.
Letters to Editor
Letter to Editor presents the author’s opinion (up to ~1000 words limited to one figure/table with limited references). If such a letter criticizes an article already published in the journal, then the authors of the original article will be given a chance to respond in the same issue in which the letter is published.
Title: Lengthy systematic names and complicated/numerous chemical formulae should be avoided where possible.
Authors’ names: Full names (First, Middle and Last) for all the authors of an article should be given and specified with superscript number(s) for the affiliation(s) [e.g., Mark Junior Smiths1]. The name of the corresponding author(s) should be specified with an asterisk after name (e.g., Mark Junior Smiths*). Where the family name may be ambiguous (e.g., a double name), please indicate this clearly.
Affiliation: Affiliation of all the authors should be given and specified with superscripted number before address (e.g., 1Faculty of …..).
Running title: A very short running title should be given.
Corresponding author: Full address, telephone and fax numbers (with country and area code) and email of the corresponding author(s) should be given.
Abstract: A factual concise abstract (up to 250 words) is required for every manuscript. The abstract should briefly state the Introduction, Methods, Results and Conclusion. An abstract is often presented separately from the article; hence it must be able to stand alone. Referencing should be avoided. Also, non-standard or uncommon abbreviations should be avoided, however, if essential they must be defined at their first mention in the abstract itself.
Key words: Immediately after the abstract, three to six relevant keywords should be included. (Notice: Readers are increasingly used search engines to find literature using keywords; thus, recognizable and searchable keywords should be given to maximize the visibility of the article.)
Original research papers can also be published in a brief format. Submitted papers that are of interest but are not acceptable as a full-length original contribution are offered by the editor to be published in this section. Also, the authors can primarily submit their papers for consideration of publication in this section. An unstructured abstract not longer than 200 words is required for this section. The body of the manuscript should not exceed 2000 words, and no heading or subheading should be used. Tables and/or Figures should be limited to 2 ones and references to 15 in maximum.
This section should clearly and briefly (up to 600 words) provide an adequate background with relevant references, avoiding a detailed literature survey or a summary of the results. The last paragraph should address the main objectives of the work.
Patients and Methods (Materials and Methods for preclinical investigations)
This section should provide sufficient details to allow the work to be reproduced, with details of supplier (i.e., company’s name, city, country) and catalogue number when appropriate. Methods already published, should be indicated by a reference: only relevant modifications should be described. The company’s name, city and country of manufacturer of the major equipment should be given. Unexpected hazards encountered during the experimental work should be noted. Any unusual hazards inherent in the use of chemicals, procedures or equipments in the investigation should be clearly identified. In cases where a study involves the use of live animals or human subjects, the author should include a statement that all experiments were performed in compliance with the relevant laws and institutional guidelines, and also state the institutional committee(s) that has approved the experiments. They should also include a statement that informed consent was obtained for any experimentation with human subjects.
Results should be clear, descriptive and concise. Attention should be paid to the matter of significant figures and tables. The same data should not be presented in more than one figure or in both a figure and a table. Basically, as a rule, interpretation of the results should be reserved for the discussion section of a full original research article.
The discussion should explore the significance of the results of the work (without repeating them) in comparison with others similar reports. Extensive citations and discussion of published literature should be avoided.
The main question of the work should be very concisely stated and the final conclusions of the study may be presented in a short “Conclusions” section, which may stand alone or form a subsection of a Discussion or Results and Discussion section(s).
Submit your text in DOC format.
Tables should be created with a word processor and saved in either DOC or RTF format. Do not embed tables in your text. Tables should be on separate pages and saved as one file in DOC format.
To ensure the highest print quality, the figures must be submitted in either TIF or EPS format according to the following minimum resolutions:
- 1200 dpi (dots per inch) for black and white line art (simple bar graphs, charts, etc.)
- 300 dpi for halftones (black and white photographs)
- 600 dpi for combination halftones (photographs that also contain line art such as labeling or thin lines), figures should be saved as individual files. Vector-based figures (e.g. figures created in Adobe Illustrator) should be submitted in EPS format.
Color figures must be submitted in a CMYK color.
Please see the ethical issue provided in the below link
Every experimental or clinical study may raise controversial ethical issues (e.g., Institutional Ethical Approval for working with animal or human subjects). Thus, Journal of Herbmed Pharmacology expects all authors, reviewers and editors to consider COPE, ICMJE and Equator Network’s reporting guidelines in medical ethics plus scientific writing. If any, authors should state related declaration(s), otherwise the following sentence should be given “None to be declared". Please take a look at the review process in Journal of Herbmed Pharmacology.
The cover letter must include a statement declaring that the study complies with current ethical considerations.
Ethical issues (including plagiarism, misconduct, data fabrication, falsification, double publication or redundancy) must completely considered by the authors.
Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that: (1) informed consent was obtained from each patient enrolled in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
Every experimental or clinical study may raise controversial ethical issues (e.g., Institutional Ethical approval for working with animal or human subjects).
Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that, the project was done with consideration of ethical issues and obtaining license from the ethics committee of local university/research center and obtaining the written consent of participants. Also, it was done according to ethical standards of human experimentation in accordance to the Helsinki Declaration (www.cirp.org/library/ethics/helsinki).
Authors reporting experimental studies on animal subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that, the project was done with consideration of ethical issues and obtaining license from the ethics committee of local institute . Also, the general care of the experimental animals used for this study was done in compliance with the Animal Welfare Act (http://www.nap.edu/openbook.php?record_id=5140&page=114).
In the case of research on human subjects, informed consent and other ethical considerations should be mentioned in the "methods" section of the manuscript. The author should include a statement that informed consent was obtained for any experimentation with human subjects. As JHP follows ICMJE, please consider their guideline for more information. In cases where a study involves the use of live animals or human subjects, the author should also include a statement that all experiments were performed in compliance with the relevant laws and institutional guidelines, and also state the institutional committee(s) that has approved the experiments. Moreover, the templates can be seen from WHO.
Conflict of Interests
The authors must declare any conflict of interests of contributed authors very briefly in a separate paragraph at the end of the paper. All sources of funding should be declared; unless otherwise the following sentence should be given “Authors declare no conflict of interests”.
To prevent the information on potential conflict of interest for authors from being overlooked or misplaced, mention this information in the cover letter. Authors must identify any potential financial conflicts of interest before the review process begins. Declared conflict of interest will not automatically result in rejection of paper but the editors reserve the right to publish any declared conflict of interest alongside accepted. The following would generally be regarded as potential conflicts of interest:
1. Direct financial payment to an author for the research or manuscript production by the sponsor of a product or service evaluated in an article.
2. Ownership of shares by an author in the company sponsoring a product service evaluated in an article (or in a company sponsoring a competing product).
3. Personal consultant for companies or other organizations with a financial interest in the promotion of particular health care products and services.
Source of Funding
Authors are required to specify the source of funding for their research when submitting a paper. Suppliers of materials should be named and their location (town, state/county, country) included. The information will be disclosed in the Acknowledgements section of the published article.
If your paper is accepted, the author identified as the formal corresponding author for the paper, the corresponding author should study and accept the copyright statement that is available on the journal website.
Authors should acknowledge any scientific, technical, statistical and financial supports. Contributors other than coauthors may be very briefly acknowledged in a separate paragraph at the end of the paper. All sources of funding should be declared.